GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
| 
                               
                            
                                
                                                                Synonyms: B1287 | E5564
                                 
                                                         
                            
                            
                            
                                Compound class: 
                                                            Synthetic organic
                                 
                                
                                    
                                        Comment: Eritoran is a synthetic analogue of lipid A, the bacterial LPS component. It is referred to as a Toll-like receptor 4 (TLR4) antagonist, but rather than direct interaction, eritoran binds to MD-2 and prevents formation of the MD-2.TLR4 protein complex. Thus, eritoran appears to antagonise LPS-induced TLR4 activation. 
                            
                            
                          
                                
                                    
                                
                          
                                   
                                   
                                  
                                    
                                    
                                    Eritoran has been investigated as a therapeutic for the management of sepsis, but failed to show sufficient clinical effect [1].  | 
                                    
                                        
                                         
  | 
                                    
                                
                                |||||||||||||||||||||||||||||||||||
For advanced searching click here to open chemical structure editor
Similar Ligands ![]()  | 
                                                                            |||||||||
                                                                                    
  | 
                                                                            
                                                                                
                                                                                
                                                                                
                                                                                
                                                                                    
  | 
                                                                            
                                                                                
                                                                                    ||||||||
                                                                                    
  | 
                                                                            
                                                                            |||||||||